The role of post‐translational modifications in cardiac hypertrophy

Abstract excerpt

Pathological cardiac hypertrophy involves excessive protein synthesis, increased cardiac myocyte size and ultimately the development of heart failure. Thus, pathological cardiac hypertrophy is a major risk factor for many cardiovascular diseases and death in humans. Extensive research in the last decade has revealed that post-translational modifications (PTMs), including phosphorylation, ubiquitination,...

Topics

Join the communities discussing this publication.

• Cardiac Fibrosis and Remodeling
• Peptidase Inhibition and Analysis
• Signaling Pathways in Disease